Our mission
Announce news
Subscribe
← Latest venture news
BrightEdge
investment portfolio and recent venture funding rounds
🔗
acsbrightedge.org
£90m
CellCentric raises £90m Series C led by RA Capital and Forbion to advance first-in-class cancer drug
Series C
Biotechnology
May 19, 2025
🔗
cellcentric.com
